Latest filing published 02 Jul 2020 for Fusion Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
HealthCap VII, L.P.: trading record in brief
HealthCap VII, L.P. discloses dealings in 2 companies, chiefly Aprea Therapeutics, Inc. and Fusion Pharmaceuticals Inc. Over a trading history stretching from 7 October 2019 to 30 June 2020, the count stands at 6 filings.
The open-market record is one-sided, with 2 purchases worth €7.3M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings 1 purchase and no sales.
The record was last updated on 2 July 2020 with a transaction in Fusion Pharmaceuticals Inc. The clock since the last published purchase (2 July 2020) now reads 2,321 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to HealthCap VII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,069,902 sharesCommon SharesSEC:0000899243-20-018256:1
- 2,497,345 sharesCommon SharesSEC:0000899243-20-018256:0
- 240,000 shares@ US$17.00100.0% of flowCommon SharesSEC:0000899243-20-018256:2Canonical exit: 28 Sept 2020 (T+90)
- 1,661,382 sharesCommon StockSEC:0000899243-19-025205:0
- 427,496 sharesCommon StockSEC:0000899243-19-025205:1
- 266,667 shares@ US$15.00Common StockSEC:0000899243-19-025205:2Canonical exit: 5 Jan 2020 (T+90)
6 of 5 declarations